Drawing for PATHOQ

USPTO serial 79413517

PATHOQ

Reviewed by CopyMark Law Group

Reg. 8026609Status 700Registered
Filing date
Status date
Registration date
Nov 18, 2025
Examiner
SUAREZ, MARIA VICTORIA
Law office
TMO LAW OFFICE 133

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with PATHOQ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Kevin L. Russell

Kevin L. Russell CHERNOFF VILHAUER LLP111 SW COLUMBIA STREETSUITE 1080PORTLAND, OR 97201

Goods and services

ClassDescriptionStatusFirst use
001Enzyme preparations for industrial purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; diagnostic preparations, other than for medical or veterinary purposes; biological preparations, other than for medical or veterinary purposes, namely, biological preparations for use in industry and science, biological preparation for use in cell cultures other than for medical or veterinary use; bacteriological preparations, namely, bacteriological culture mediums other than for medical and veterinary use; biological tissue cultures, other than for medical or veterinary purposes; preparations of microorganisms, other than for medical and veterinary use; biochemical catalysts; reagent paper, other than for medical or veterinary purposesACTIVE—
005Reagent paper for medical purposes; diagnostic biomarker reagents for medical purposes; cultures of microorganisms for medical or veterinary use; bacteriological preparations for medical and veterinary use; bacterial preparations for medical and veterinary use; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer, biological preparations for use in cell cultures for medical purposes, biological preparations for the treatment of immune system related diseases and disorders; chemical preparations for medical purposes, namely, chemical preparations for the treatment of cancer; chemical preparations for medical purposes, namely, chemical preparations for sanitary use; chemical preparations for medical purposes, namely, chemical preparations for the diagnosis of tumors, reproductive and immune system related diseases and disorders; enzyme preparations for medical purposes; diagnostic preparations for medical purposes; chemical reagents for medical or veterinary purposesACTIVE—
042Research and development of new products for others; technological research in the field of DNA sequencing; technological research in the field of cell engineering technology; scientific and technological services, namely, technological research on tumors and tumor microenvironment, immunology, signaling pathways, molecular biology, and cell biology in the life science research field; chemical analysis; chemistry services, namely, research and development in the field of chemistry; chemical research; bacteriological research; biological research; conducting clinical trials for others; medical research; Medical research laboratoriesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 5, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 21, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 21, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Jun 25, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jun 6, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Jun 5, 2026FIMPFINAL DISPOSITION PROCESSED—
Apr 14, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 14, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 14, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 18, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Nov 18, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Nov 18, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Sep 30, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 30, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 24, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 29, 2025RFNPREFUSAL PROCESSED BY IB—
Aug 29, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 29, 2025ATRVATTORNEY REVIEW COMPLETED—
Aug 29, 2025CREVCORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED—
Aug 26, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 26, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 26, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 31, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 23, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 23, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 23, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 23, 2025DOCKASSIGNED TO EXAMINER—
May 31, 2025RFNTREFUSAL PROCESSED BY IB—
May 23, 2025CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
May 7, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 7, 2025RFRRREFUSAL PROCESSED BY MPU—
Mar 20, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 19, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 19, 2025DOCKASSIGNED TO EXAMINER—
Jan 14, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 13, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 13, 2025LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Jan 2, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance